Article
Mutant IDH1 Promotes Glioma Formation In Vivo
1 May 2018
Abstract excerpt
Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II–III glioma and secondary glioblastoma (GBM). A causal role for IDH1 R132H in gliomagenesis has been proposed, but functional validation in vivo has not been demonstrated. In this study, we assessed the role of IDH1 R132H in glioma development in the context of clinically relevant cooperating genetic alterations in vitro and in vivo ....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
